Citigroup’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $498K | Sell |
43,727
-96,739
| -69% | -$1.1M | ﹤0.01% | 2934 |
|
|
2025
Q1 | $1.67M | Buy |
140,466
+33,116
| +31% | +$393K | ﹤0.01% | 2214 |
|
|
2024
Q4 | $2.02M | Buy |
107,350
+57,757
| +116% | +$1.09M | ﹤0.01% | 2123 |
|
|
2024
Q3 | $1.11M | Buy |
49,593
+22,171
| +81% | +$498K | ﹤0.01% | 2487 |
|
|
2024
Q2 | $572K | Sell |
27,422
-157,358
| -85% | -$3.28M | ﹤0.01% | 2614 |
|
|
2024
Q1 | $2.72M | Buy |
184,780
+169,635
| +1,120% | +$2.49M | ﹤0.01% | 1616 |
|
|
2023
Q4 | $156K | Sell |
15,145
-27,055
| -64% | -$279K | ﹤0.01% | 3292 |
|
|
2023
Q3 | $332K | Sell |
42,200
-4,760
| -10% | -$37.4K | ﹤0.01% | 2695 |
|
|
2023
Q2 | $469K | Sell |
46,960
-66,144
| -58% | -$661K | ﹤0.01% | 2781 |
|
|
2023
Q1 | $1M | Buy |
113,104
+39,508
| +54% | +$351K | ﹤0.01% | 2010 |
|
|
2022
Q4 | $808K | Sell |
73,596
-46,922
| -39% | -$515K | ﹤0.01% | 2205 |
|
|
2022
Q3 | $1.57M | Buy |
120,518
+45,253
| +60% | +$590K | ﹤0.01% | 1774 |
|
|
2022
Q2 | $954K | Buy |
75,265
+50,085
| +199% | +$635K | ﹤0.01% | 2119 |
|
|
2022
Q1 | $353K | Sell |
25,180
-51,431
| -67% | -$721K | ﹤0.01% | 3068 |
|
|
2021
Q4 | $2.22M | Sell |
76,611
-44,041
| -37% | -$1.28M | ﹤0.01% | 1903 |
|
|
2021
Q3 | $3.62M | Sell |
120,652
-1,859
| -2% | -$55.7K | ﹤0.01% | 1473 |
|
|
2021
Q2 | $3.25M | Buy |
122,511
+37,755
| +45% | +$1M | ﹤0.01% | 1747 |
|
|
2021
Q1 | $2.64M | Buy |
84,756
+81,242
| +2,312% | +$2.53M | ﹤0.01% | 1764 |
|
|
2020
Q4 | $116K | Buy |
3,514
+2,981
| +559% | +$98.4K | ﹤0.01% | 3586 |
|
|
2020
Q3 | $19K | Buy |
+533
| New | +$19K | ﹤0.01% | 3997 |
|